No Password Required: Threat Researcher at Cisco Talos and a Veteran of the Highest-Profile Cyber Incidents Who Roasts His Own Coffee Beans
High Crimes and Misdemeanors: The FAA and Pilot DUIs
High Crimes and Misdemeanors: Busted by the Feds: The Anatomy of a Federal Criminal Prosecution of a Drone Pilot
High Crimes and Misdemeanors: Unruly Passengers on Flights
High Crimes and Misdemeanors: Federal Criminal Aviation Cases From 2021
WEBINAR: The ABCs of Pilot Deviations
Compliance into the Weeds: Episode 115-Regulatory Capture and Regulatory Approval at the FAA
K&L Gates Triage: Using Drones in Medicine
Unmanned Aircraft Systems
No Tariffs on Aerospace Products Traded Between U.S. and European Union - On July 27, 2025, the U.S. and EU reached a trade agreement. As part of the agreement, the U.S. will impose a 15 percent tariff “on the vast majority...more
Differences in law as well as cultural differences can prolong international aircraft transactions. Assembling a good team of legal and technical professionals, as well as an aircraft broker familiar with international...more
Last week, the Executive Order on Protecting the United States from Certain Unmanned Aircraft Systems (UAS) expanded the U.S.-China drone controversy to North Korea, Iran, and Russia....more
This Week: House passes Broadband Deployment Accuracy and Technological Availability (DATA) Act, House Energy and Commerce holds hearing on sale of fake products as bipartisan Judiciary Committee leaders introduce SAFE SHOP...more
Home speaker maker Sonos has sued Google, accusing the company of “infringing on five of its patents, including technology that lets wireless speakers connect and synchronize with one another.” Sonos had originally partnered...more
The U.S. and China have tentatively [maybe?] agreed that a first phase of a trade agreement “would roll back a portion of the tariffs placed on each other’s products, a significant step toward defusing tensions between the...more
Amgen will pay $13.4 billion in cash to buy psoriasis treatment Otezla, a deal that will “pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene” by addressing “regulatory concerns over their union”....more